FIELD: chemical-pharmaceutical industry, medicine, pharmacy.
SUBSTANCE: invention relates to a solid medicinal formulation of hepatoprotective effect that comprises combination of flavanolignan with phopholipids as active components and special additive - colloidal silicon dioxide, polyvinylpyrrolidone, trehalose, sodium stearylfumarate, calcium phosphate and/or mannitol. Method for preparing this medicinal formulation involves a wetting step of mixture of phospholipid with colloidal silicon dioxide with small amount of water in the mass ratio about 2:1, respectively, addition of flavanolignan, calcium phosphate and/or mannitol, trehalose followed by wetting the mixture with 15% polyvinylpyrrolidone aqueous solution, wet and dry granulation and powdering dry granulate with sodium stearylfumarate. Agent is prepared in form of capsule preferably. Invention provides simplifying technology and enhancing stability of agent and expands assortment of agents of hepatoprotective effect.
EFFECT: improved and valuable medicinal properties of formulation.
4 cl, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
MEDICATION, POSSESSING HEPATOPROTECTIVE, DETOXICATING AND REGENERATING ACTION | 2007 |
|
RU2418601C2 |
COMBINED AGENT CONTAINING UDCA, HYMECROMONE AND SILYMARIN (VERSIONS) | 2017 |
|
RU2738444C2 |
PHARMACEUTICAL HEPATOPROTECTIVE COMPOSITION AND TREATMENT METHOD | 2008 |
|
RU2391989C2 |
COMPOSITION OF HYPOLIPIDEMIC AND HEPATOPROTECTIVE ACTIVITY | 2007 |
|
RU2329051C1 |
USE OF FLAVANOLIGNANS AS DRUGS SHOWING ANTIPROLIFERATIVE ACTIVITY WITH RESPECT TO TUMORS OF UTERUS, OVARY AND MAMMARY GLAND | 1995 |
|
RU2161488C2 |
PHARMACEUTICAL COMPOSITION BASED ON HEPATOPROTECTOR AND PREBIOTIC AND METHOD FOR PRODUCING AND APPLYING THE COMPOSITION | 2006 |
|
RU2318538C1 |
HEPATOPROTECTIVE INJECTION PHARMACEUTICAL COMPOSITION ON THE BASIS OF SILIMARINE AND NANOPARTICLES OF SELENIUM | 2017 |
|
RU2645092C1 |
METHOD OF OBTAINING MEDICAL FORM OF TRIMETAZIDINE OF PROLONGED ACTION | 2012 |
|
RU2530558C2 |
DIOSMIN SOLID MEDICINAL FORMULATION | 2005 |
|
RU2314812C2 |
PHARMACEUTICAL ANTI-TUBERCULOSIS COMBINED COMPOSITION | 2011 |
|
RU2478389C2 |
Authors
Dates
2008-01-20—Published
2006-02-07—Filed